Celularity Inc.
CELU
$0.69
-$0.12-15.20%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 26.55M | 40.58M | 44.59M | 50.97M | 54.22M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 26.55M | 40.58M | 44.59M | 50.97M | 54.22M |
| Cost of Revenue | 20.07M | 20.04M | 20.02M | 16.90M | 14.99M |
| Gross Profit | 6.48M | 20.54M | 24.57M | 34.06M | 39.23M |
| SG&A Expenses | 51.27M | 52.26M | 55.60M | 58.88M | 58.64M |
| Depreciation & Amortization | -418.00K | 1.44M | 1.49M | 1.58M | 1.75M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 85.95M | 89.25M | 91.94M | 92.63M | 92.77M |
| Operating Income | -59.40M | -48.67M | -47.35M | -41.66M | -38.55M |
| Income Before Tax | -91.71M | -80.65M | -73.67M | -55.63M | -57.89M |
| Income Tax Expenses | 3.00K | -- | -- | -- | -- |
| Earnings from Continuing Operations | -91.72 | -80.65 | -73.67 | -55.63 | -57.89 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -91.72M | -80.65M | -73.67M | -55.63M | -57.89M |
| EBIT | -59.40M | -48.67M | -47.35M | -41.66M | -38.55M |
| EBITDA | -52.61M | -41.36M | -39.91M | -34.06M | -30.63M |
| EPS Basic | -3.60 | -3.33 | -3.19 | -2.47 | -2.65 |
| Normalized Basic EPS | -1.94 | -1.90 | -1.80 | -1.38 | -1.54 |
| EPS Diluted | -3.60 | -3.33 | -3.19 | -2.47 | -2.65 |
| Normalized Diluted EPS | -1.94 | -1.90 | -1.80 | -1.38 | -1.54 |
| Average Basic Shares Outstanding | 102.35M | 96.19M | 91.82M | 89.65M | 87.56M |
| Average Diluted Shares Outstanding | 102.35M | 96.19M | 91.82M | 89.65M | 87.56M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |